Tag Archives: Magoolas

Dr. Magoola’s Dei BioPharma make U.S. patent application for global ebola vaccine platform

Dr Magoolas Dei BioPharma make US patent application for global.webp

Dr. Mathias Magoola – New mRNA innovation targets major outbreak-causing ebolaviruses, including Zaire, Sudan, Bundibugyo and the West African/Makona lineage KAMPALA, Uganda — Dei BioPharma has announced the submission of a utility patent application to the United States Patent and Trademark Office for a next-generation mRNA vaccine platform designed to provide broad protection against the world’s most dangerous Ebola-causing viruses. × …

Read More »

Magoola’s Dei Biopharma Loses Top Scientists as Massive Exodus Hits Ugandan Vaccine Conglomerate

Screenshot_20250930-170700~2

Kampala/Matugga – Troubling signs are emerging from Uganda’s flagship pharmaceutical and biotechnology giant, Dei Biopharma, as reports confirm a massive exodus of top scientists and senior managers from the company’s state-of-the-art vaccine and drug manufacturing complex in Kigogwa–Matugga. The Dei Biopharma manufacturing facility in Matugga, near Kampala, Once hailed as a landmark investment that would anchor Africa’s healthcare self-sufficiency, the …

Read More »